Displaying results 1 - 10 / 16
results / page
What publication information is included in the service?
Publication name
Authors
Publication channel
Year
Publications information icon

Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei

Peer-reviewed
Open access
DOI
10.1016/j.humpath.2016.02.022
Nummela, Pirjo; Leinonen, Hannele; Järvinen, Petrus; Thiel, Alexandra; Järvinen, Heikki; Lepisto, An...
Human pathology2016Publications information icon

Predicting Circulating CA125 Levels among Healthy Premenopausal Women

Peer-reviewed
Open access
DOI
10.1158/1055-9965.EPI-18-1120
Sasamoto, Naoko; Babic, Ana; Rosner, Bernard A.; Fortner, Renee T.; Vitonis, Allison F.; Yamamoto, H...
Cancer epidemiology biomarkers and prevention2019Publications information icon

A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer

Peer-reviewed
Open access
DOI
10.1016/j.ygyno.2019.12.025
Salminen, Liina; Nadeem, Nimrah; Jain, Shruti; Grènman, Seija; Carpén, Olli; Hietanen, Sakari; Oksa,...
Gynecologic oncology2020Publications information icon

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer

Peer-reviewed
Open access
DOI
10.3390/cancers15092605
Lombaers Marike S., Cornel Karlijn M. C., Visser Nicole C. M., Bulten Johan, Kuesters-Vandevelde Hei...
Cancers2023Publications information icon

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125

Peer-reviewed
Open access
DOI
10.1038/s42003-020-01191-x
Sherif Bayoumy, Heidi Hyytiä, Janne Leivo, Sheikh M. Talha, Kaisa Huhtinen, Matti Poutanen, Johanna ...
Communications Biology2020Publications information icon

Glycovariant-based lateral flow immunoassay to detect ovarian cancer-associated serum CA125

Peer-reviewed
Open access
Bayoumy S; Hyytiä H; Leivo J; Talha SM; Huhtinen K; Poutanen M; Hynninen J; Perheentupa A; Lamminmäk...
Communications Biology2020Publications information icon

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

Peer-reviewed
DOI
10.1373/clinchem.2016.257691
Gidwani, Kamlesh; Huhtinen, Kaisa; Kekki, Henna; van Vliet, Sandra; Hynninen, Johanna; Koivuviita, N...
Clinical chemistry2016Publications information icon

CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242

Peer-reviewed
Open access
DOI
10.3233/TUB-200069
Björkman, Kajsa; Mustonen, Harri; Kaprio, Tuomas; Kekki, Henna; Pettersson, Kim; Haglund, Caj; Böcke...
Tumor biology2021Publications information icon

Exploratory Analysis of CA125-MGL and -STn Glycoforms in the Differential Diagnostics of Pelvic Masses

Peer-reviewed
Open access
DOI
10.1093/jalm/jfz012
Salminen, Liina; Nadeem, Nimrah; Rolfsen, Anne Lone; Dorum, Anne; Laajala, Teemu D.; Grenman, Seija;...
The journal of applied laboratory medicine2020Publications information icon

Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors

Peer-reviewed
Nissi, Ritva; Talvensaari-Mattila, Anne; Kuvaja, Paula; Pääkko, Paavo; Soini, Ylermi; Santala, Markk...
Anticancer research2015

Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei

Peer-reviewed
Open access
DOI
10.1016/j.humpath.2016.02.022
2016

Predicting Circulating CA125 Levels among Healthy Premenopausal Women

Peer-reviewed
Open access
DOI
10.1158/1055-9965.EPI-18-1120
2019

A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer

Peer-reviewed
Open access
DOI
10.1016/j.ygyno.2019.12.025
2020

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer

Peer-reviewed
Open access
DOI
10.3390/cancers15092605
2023

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125

Peer-reviewed
Open access
DOI
10.1038/s42003-020-01191-x
2020

Glycovariant-based lateral flow immunoassay to detect ovarian cancer-associated serum CA125

Peer-reviewed
Open access
2020

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

Peer-reviewed
DOI
10.1373/clinchem.2016.257691
2016

CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242

Peer-reviewed
Open access
DOI
10.3233/TUB-200069
2021

Exploratory Analysis of CA125-MGL and -STn Glycoforms in the Differential Diagnostics of Pelvic Masses

Peer-reviewed
Open access
DOI
10.1093/jalm/jfz012
2020

Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors

Peer-reviewed
2015